Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/0OT stock hub

FRA/0OT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/0OTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.8B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/0OTFRA/0OT

—

Loading chart…

In the news

Latest news · FRA/0OT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-68.6

P25 n/aP50 n/aP75 n/a

ROIC-37.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/0OT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

160

Groups with data

Currency

USD

Showing 160 of 160 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	325
Employees Change	51%
Employees Change Percent	18.61
Enterprise value	EUR 1.3B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 1.8B
Price	EUR 8.2
Price currency	EUR
Rev Per Employee	138,869.41x
Sic	2836
Symbol	fra/0OT
Website	https://www.ocutx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-14.03%
EV Earnings	-5.14x
EV/FCF	-6.2x
EV/Sales	29.32x
FCF yield	-11.64%
P/B ratio	3.56x
P/S ratio	39.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -151.8M
Net Income	EUR -251.9M
Pretax Margin	-558.24%
Profit Per Employee	EUR -775,227
ROA	-32.88
Roa5y	-25.86
ROCE	-43.72
ROE	-68.55
Roe5y	-80.17
ROIC	-37.31

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.11%
Cagr1y	31.94%
Cagr3y	13.42%
Cagr5y	-9.49%
Revenue Growth	-12.76x
Revenue Growth Q	0.81x
Revenue Growth3 Y	0.23x
Revenue Growth5 Y	18.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.09
Assets	EUR 635.3M
Cash	EUR 578.2M
Current Assets	EUR 598.7M
Current Liabilities	EUR 40.4M
Debt	EUR 68.9M
Debt Equity	EUR 0.14
Debt FCF	EUR -0.33
Equity	EUR 504.4M
Interest Coverage	-25.75
Liabilities	EUR 130.9M
Long Term Assets	EUR 36.7M
Long Term Liabilities	EUR 90.5M
Net Cash	EUR 509.3M
Net Cash By Market Cap	EUR 28.37
Net Cash Growth	114.75%
Net Debt Equity	EUR -1.01
Tangible Book Value	EUR 504.4M
Tangible Book Value Per Share	EUR 2.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.81
Inventory Turnover	64.83
Net Working Capital	EUR -4.5M
Quick ratio	14.49
Working Capital	EUR 571M
Working Capital Turnover	EUR 0.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-19.87%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-10.58%
1Y total return	31.92%
200-day SMA	9.34
3Y total return	45.91%
50-day SMA	7.67
50-day SMA vs 200-day SMA	50under200
5Y total return	-39.26%
All Time High	39.99
All Time High Change	-79.49%
All Time High Date	2015-03-16
All Time Low	1.88
All Time Low Change	336.17%
All Time Low Date	2023-11-17
ATR	0.28
Ch YTD	-20.47
High	8.2
High52	13.66
High52 Date	2025-12-09
High52ch	-39.97%
Low	8.2
Low52	5.68
Low52 Date	2026-02-17
Low52ch	44.37%
Ma50ch	6.98%
Price vs 200-day SMA	-12.19%
RSI	57.61
RSI Monthly	51.52
RSI Weekly	48.33
Sharpe ratio	0.67x
Sortino ratio	1.09
Total Return	-19.87%
Tr YTD	-20.47
Tr1m	21.48%
Tr1w	3.15%
Tr3m	7.44%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -259.7M
Operating margin	-575.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	216,603,291%
Shares Insiders	1.08%
Shares Institutions	88.89%
Shares Qo Q	0.53%
Shares Yo Y	19.87%
Short Ratio	4.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -250.9M
Average Volume	12.5x
Bv Per Share	2.3
CAPEX	EUR -12.8M
Ch10y	-10.58
Ch1m	21.48
Ch1w	3.15
Ch1y	31.92
Ch3m	7.44
Ch3y	45.91
Ch5y	-39.26
Ch6m	-8.17
Change	1.86%
Change From Open	0
Close	8.05
Days Gap	1.86
Depreciation Amortization	3,921,824.3
Earnings Date	2026-05-05
EBIT	EUR -259.7M
EBITDA	EUR -255.7M
EPS	EUR -1.26
F Score	2
FCF	EUR -209M
FCF EV Yield	-16.12x
Financing CF	483,807,694
Fiscal Year End	December
Founded	2,006
Investing CF	-12,670,386
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Ma150	8.97
Ma150ch	-8.6%
Ma20	7.81
Ma20ch	5.06%
Net CF	274,949,711
Next Earnings Date	2026-08-07
Open	8.2
Ppne	21,131,213
Price Date	2026-05-08
Ptbv Ratio	3.56
Relative Volume	20x
Revenue	45,132,557x
SBC By Revenue	92.84x
Share Based Comp	41,899,263
Tr6m	-8.17%
Volume	0
Z Score	5.3

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/0OT pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/0OT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/0OT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+88.9%

Share of float held by funds and institutions

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/0OT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.6

Neutral momentum band

Price vs 200-day MA

-12.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.67

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/0OT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/0OT stock rating?

fra/0OT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/0OT analysis?

The full report lives at /stocks/fra/0OT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/0OT?

The latest report frames fra/0OT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/0OT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.